Genetyka 360º

Aktualności

Genomtec in numbers

16
liczba przyznanych patentów
+35
liczba zgłoszeń patentowych
10
lat dostarczamy rozwiązania diagnostyczne
1st
Global leader in isothermal amplification solutions AI-powered

What makes us unique

We have created a broad IP portfolio enabling all aspects of our solutions

Proprietary AI approaches drive rapid assay design

We have developed, validated and published diagnostic test menu in all market segments

We have device and engineering capabilities
including scale up manufacturing

Exclusive team has significant technical and commercial exoerience

Poland is at the center of Europe,
cost effective and growing

Services & partnership areas

Markets we serve

Life Sciences

$88B today
11.75% CAGR

Clinical Diagnostics

$86B today
6% CAGR

Food Safey

$25B today
7% CAGR

Veterinary

$8B today
9.75% CAGR

Pets

$3.6B today
9% CAGR

Bio Security

Zobacz więcej$5.5B today
13% CAGR

Nagrody

December 2020

3rd place

Genomtec took third place in the 2020 “Maker in China” competition, directly supported by the China-CEEC SME Research Institute Government Organisation, in which over 300 companies from Central and Eastern Europe and China compete. Genomtec ID is attracting the attention of Chinese investors, and the company is reassured that its efforts will be backed by the Chinese government’s anticipated expansion in that market at the local and central level.

November 2020

2nd place

Genomtec took second place in the 4th edition of the international competition “China Shenzhen Innovation & Entrepreneurship” and received an award of RMB 650,000 RMB, which is about PLN 400,000. Its innovative Genomtec ID platform beat out international competition with 1,046 projects entered. This win opens up new business and development opportunities on the Chinese market for the Company.

May 2019

1st place

Genomtec wins the “Next Health Investment Pitch” competition organised for Polish companies who want to define economic reality through their innovations via Amgen and ImpactCEE. Amgen has been an international pioneer in biotechnology since 1980 and one of the world leaders in the production of biological medicines.

March 2019

1st place

Genomtec won the “Start Up Med” competition organised by the 4th Health Challenges Congress, a forum for a multi-topic discussion on key issues for healthcare systems in Europe.

December 2018

Finalist

Genomtec was one of the five finalists of “InCredibles” – an acceleration program aimed at the most innovative and promising entrepreneurs organised by Kulczyk Investments.

December 2018

2nd place

Genomtec won second place in the “Shark Tank” competition organised by New Frontiers in Interventional Cardiology, during an international educational and industry meeting for representatives of medicine and related fields in cardiology, surgery and cardiac/vascular imaging.

November 2018

Distinction

Genomtec received a distinction in the “Eagle of Innovation” competition organised by Rzeczpospolita in the category of product and service innovations. In this competition, Rzeczpospolita honours young companies – start-ups – that offer innovative and value-creating products or services.

October 2018

1st place

Genomtec took 1st place as the best non-US start-up participating in HUBweek, an annual innovation festival held since 2014 by The Boston Globe, Harvard University, Massachussetts General Hospital, which brings together the most creative minds that influence art, science, and technology.

October 2018

Distinction

Genomtec received a distinction in the competition “Architects of Innovation” in the category of “emerging technologies”, which aims to distinguish companies and institutions that focus on innovative solutions, enter new markets, and are not afraid to be a precursor of new trends.

October 2018

Finalist

Genomtec was one of the finalists of the Biomed PFR Academy, an educational initiative for innovative pharmaceutical and medical companies.

October 2018

Distinction

Genomtec received a distinction in the competition “Architects of Innovation” in the category of “emerging technologies”, which aims to distinguish companies and institutions that focus on innovative solutions, enter new markets, and are not afraid to be a precursor of new trends.

August 2018

Distinction

Miron Tokarski, co-founder and CEO of Genomtec was included on the “Forbes: 30 under 30” list, composed of the most promising young entrepreneurs, innovators, investors, managers, economists and business activists in Poland.

July 2018

1st place

Genomtec won the “CVC Young Innovator Awards” competition organised by MIT Enterprise Forum Poland in the acceleration program for start-ups from Central and Eastern Europe in collaboration with MIT and world leading investment funds, such as CVC Capital, dynamically supporting the company’s development.

June 2018

1st place

Genomtec received the main “Innovation Initiator” award in the “Start-up” category from Newsweek Polska in a competition rewarding and promoting companies and institutions for whom innovation is the primary goal.

June 2018

3rd place

Genomtec won a bronze medal in the “Pitch to London” annual competition for the best start-ups from Poland, during which they had the opportunity to present themselves to British experts and investors.

June 2018

9th place

Miron Tokarski ranked 9th among the “Top 50 Creative People in Business”, a year-round program involving the exchange of knowledge, experience and business opportunities, rewarding managers for innovation and unconventional solutions in their business.

May 2018

Winner

Miron Tokarski wins the 2nd edition of the “Young Talents” competition in the “Success in innovation” category organised by the Lower Silesian Capital Club. The “Young Talents” competition aims to promote and appreciate young scientists and students from Lower Silesia who have achieved significant success.